Simplex Trading, LLC Scynexis Inc Transaction History

Simplex Trading, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$1.39 - $2.21 $646 - $1,027	-465 Reduced 4.41%	10,086 $14,000
Q4 2023 Feb 02, 2024	BUY	$1.56 - $2.24 $1,935 - $2,779	1,241 Added 13.33%	10,551 $23,000
Q3 2023 Nov 01, 2023	BUY	$1.93 - $3.64 $17,968 - $33,888	9,310 New	9,310 $21,000
Q1 2023 Apr 27, 2023	BUY	$1.15 - $3.0 $81,489 - $212,580	70,860 New	70,860 $212,000
Q2 2022 Aug 03, 2022	SELL	$1.77 - $3.87 $2,401 - $5,251	-1,357 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$3.56 - $6.66 $4,599 - $8,604	-1,292 Reduced 48.77%	1,357 $5,000
Q4 2021 Feb 23, 2022	BUY	$4.94 - $7.69 $13,086 - $20,370	2,649 New	2,649 $16,000
Q2 2021 Aug 12, 2021	SELL	$6.5 - $9.97 $15,736 - $24,137	-2,421 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$6.93 - $9.63 $13,312 - $18,499	1,921 Added 384.2%	2,421 $19,000
Q4 2020 Feb 02, 2021	BUY	$4.28 - $7.87 $2,140 - $3,935	500 New	500 $3,000

13.7M

21.9K

2.6K

Ticker SCYX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 32,651,800
Market Cap $40.5M
Description
SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.